{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:08:41Z","timestamp":1758931721626,"version":"3.44.0"},"reference-count":20,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dan Med J"],"abstract":"<jats:p>INTRODUCTION. We aimed to investigate the prevalence of opioid and benzodiazepine use among Danish youths aged 13-26 years, and to document their knowledge of opioids, benzodiazepines and overdose prevention.\n\nMETHODS. An anonymous questionnaire was distributed via email and posters at youth educational institutions, and via social media. From September 2023 to April 2024, a total of 1,222 responses were collected.\n\nRESULTS. In the present study, most adolescents and young adults knew of opioids and benzodiazepines (90.7% and 71.8%, respectively). Approximately one out of four had used one or the other at least once (opioids: 24.4%, benzodiazepines: 24.6%). One third of respondents with prior opioid use had their debut age using opioids between 16-18 (32.9%), and one third at an even younger age (32.6%). Only 7.1% reported gaining access to opioids through a doctor. Nearly one in four of the respondents had witnessed someone overdose (24.9%). However, less than half (41.2%) knew of the antidote that prevents opioid overdoses.\n\nCONCLUSIONS. Although our results may be restricted to certain Danish youth groups, knowledge and use of highly addictive substances appear widespread. Among our respondents, nearly one out of four reported prior use of opioids and benzodiazepines. The majority had their debut age using opioids at a young age, between 16 and 18 years or younger. Less than half knew of the antidote that can reverse an opioid overdose.\n\nFUNDING. Antidote Danmark.\n\nTRIAL REGISTRATION. This study was a voluntary survey and, in accordance with Danish legislation, did not require ethical approval.<\/jats:p>","DOI":"10.61409\/a08240534","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T11:16:50Z","timestamp":1753960610000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["Opioid and benzodiazepine use among adolescents and young adults in Denmark"],"prefix":"10.61409","author":[{"given":"Anne-Sofie Hartvig","family":"Kl\u00e6rke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasper","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Lodberg","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidsel Lauge","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natascha","family":"Nydal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars Gadegaard","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Leth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Adolphsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Abildgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl Martin","family":"S\u00f6derstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads","family":"Bang-Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Bang-Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob Hartvig","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,7]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Spencer MR, Mini\u00f1o AM, Warner M. Drug overdose deaths in the United States, 2001-2021. NCHS Data Brief. 2022;(457):1-8. https:\/\/doi.org\/10.15620\/cdc:122556","DOI":"10.15620\/cdc:122556"},{"key":"ref1","unstructured":"CDC, National Center for Health Statistics. U.S. overdose deaths decrease in 2023, first time since 2018. CDC, National Center for Health Statistics, 2024. www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm (25 Jun 2024)"},{"key":"ref2","unstructured":"Publications Office of the European Union. European Union Serious and Organised Crime Threat Assessment (SOCTA) 2021. A corrupting influence: the infiltration and undermining of Europe's Economy and Society by Organised Crime. Luxembourg: Publications Office of the European Union, 2021. https:\/\/data.europa.eu\/doi\/10.2813\/346806 (25 Jun 2024)"},{"key":"ref3","unstructured":"Aarhus Universitet, Syddansk Universitet, K\u00f8benhavns Universitet. Sundhedsfaglig vurdering af skadevirkning og farlighed af euforiserende stoffer. Konsensusvurdering, Institut for Retsmedicin Aarhus Universitet, Retsmedicinsk Institut Syddansk Universitet, Retsmedicinsk Institut K\u00f8benhavns Universitet. Aarhus Universitet, Syddansk Universitet, K\u00f8benhavns Universitet, 2023. https:\/\/health.au.dk\/fileadmin\/health-nyheder\/2024\/Skadevirkning_og_farlighed_af_euforiserende_stoffer.pdf Skadevirkning_og_farlighed_af_euforiserende_stoffer.pdf (26 Jun 2024)"},{"key":"ref4","unstructured":"Simonsen KW, Christoffersen DJ, Linnet K, Andersen CU. Fatal poisoning among drug users in Denmark in 2017. Dan Med J. 2021;68(1):A07200560"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Andersen CU, Ahmed H, Raedkjaer M, et al. Deaths caused by medication in persons not using illicit narcotic drugs: an autopsy study from Western Denmark. Basic Clin Pharmacol Toxicol. 2023;132(1):111-119. https:\/\/doi.org\/10.1111\/bcpt.13808","DOI":"10.1111\/bcpt.13808"},{"key":"ref6","unstructured":"Andersen SJ, Hybholt J. Brug af opioider blandt unge er nu en national tendens. TV 2 Kosmopol, 2023. https:\/\/nyheder.tv2.dk\/lokalt\/2023-06-08-brug-af-opioider-blandt-unge-er-nu-en-national-tendens (20 Jun 2024)"},{"key":"ref7","unstructured":"SSP Samr\u00e5det. Unge og opioider. En SSP-unders\u00f8gelse i de danske kommuner. SSP Samr\u00e5det, 2023. www.ism.dk\/Media\/638218846540121020\/SSP-Samraadet-Kortlaegning-Unge-og-opioider.pdf (Jun 2024)"},{"key":"ref8","unstructured":"Danish Health Authority. Unders\u00f8gelse blandt unge om brug af opioider og benzodiazepiner. Voxmeter for Sundhedsstyrelsen, 2024. www.sst.dk\/-\/media\/Udgivelser\/2024\/Stoffer\/Undersoegelse-blandt-unge-om-brug-af-opioider-og-benzodiazepiner.ashx (20 Jun 2024)"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Ellis JD, Dunn KE, Huhn AS. Harm reduction for opioid use disorder: strategies and outcome metrics. Am J Psychiatry. 2024;181(5):372-380. https:\/\/doi.org\/10.1176\/appi.ajp.20230918","DOI":"10.1176\/appi.ajp.20230918"},{"key":"ref10","unstructured":"World Health Organization. Community management of opioid overdose. World Health Organization, 2014. www.who.int\/substance_abuse\/publications\/management_opioid_overdose\/en\/ (26 Jun 2024)"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Doleac JL, Mukherjee A. The moral hazard of lifesaving innovations: naloxone access, opioid abuse, and crime. IZA Discuss Pap. 2018;11489. https:\/\/doi.org\/10.2139\/ssrn.3170278","DOI":"10.2139\/ssrn.3170278"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Jones JD, Campbell A, Metz VE, Comer SD. No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone. Addict Behav. 2017;71:104-106. https:\/\/doi.org\/10.1016\/j.addbeh.2017.03.008","DOI":"10.1016\/j.addbeh.2017.03.008"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Chimbar L, Moleta Y. Naloxone effectiveness: a systematic review. J Addict Nurs. 2018;29(3):167-171. https:\/\/doi.org\/10.1097\/JAN.0000000000000230","DOI":"10.1097\/JAN.0000000000000230"},{"key":"ref14","unstructured":"Strang J, McDonald R, Simon R, et al. Preventing opioid overdose deaths with take-home naloxone. Publications Office of the European Union. European Monitoring Centre for Drugs and Drug Addiction, 2016. https:\/\/data.europa.eu\/doi\/10.2810\/357062 (Jun 2024)"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Fischer NR. School-based harm reduction with adolescents: a pilot study. Subst Abuse Treat Prev Policy. 2022;17:79. https:\/\/doi.org\/10.1186\/s13011-022-00502-1","DOI":"10.1186\/s13011-022-00502-1"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Andelius L, Hansen CM, Lippert FK, et al. Smartphone activation of citizen responders to facilitate defibrillation in out-of-hospital cardiac arrest. J Am Coll Cardiol. 2020;76(1):43-53. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.073","DOI":"10.1016\/j.jacc.2020.04.073"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Darcy C. Drug education best practice for health, community and youth workers: a practical and accessible tool-kit. Health Educ J. 2021;80(1):28-39. https:\/\/doi.org\/10.1177\/0017896920950338","DOI":"10.1177\/0017896920950338"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Jenkins EK, Slemon A, Haines-Saah RJ. Developing harm reduction in the context of youth substance use: insights from a multi-site qualitative analysis of young people's harm minimization strategies. Harm Reduct J. 2017;14(1):53. https:\/\/doi.org\/10.1186\/s12954-017-0180-z","DOI":"10.1186\/s12954-017-0180-z"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Andersen PA, Thomsen AH, Hasselstr\u00f8m JB, et al. Exploring death scenes and circumstances in fatal opioid poisonings: Insights for preventive strategies using forensic autopsy cases in Western Denmark. Forensic Sci Int. 2024;356:111948. https:\/\/doi.org\/10.1016\/j.forsciint.2024.111948","DOI":"10.1016\/j.forsciint.2024.111948"}],"container-title":["Danish Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:07:12Z","timestamp":1758892032000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/dmj\/A08240534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.61409\/a08240534","relation":{},"ISSN":["2245-1919"],"issn-type":[{"type":"electronic","value":"2245-1919"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}